TREADWELL THERAPEUTICS
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer. Founded by a cadre of pre-eminent scientific luminaries, including Dr. Tak W. Mak, the Company's robust, internally developed pipeline includes a first-in-class PLK4 kinase inhibitor, CFI-400945, and a best-in-class TTK inhibitor, CFI-402257, and CFI-402411, an oral immunomodulatory kinase inhibitor with activity toward HPK1. Treadwell also has a robust pre-clinical pipeline with multiple biologic and next-generation TCR-based autologous cell therapy programs.
TREADWELL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.treadwelltx.com
Total Employee:
11+
Status:
Active
Total Funding:
118 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-15 | TCRyption | TCRyption acquired by Treadwell Therapeutics | N/A |
Investors List
Alpha Win Capital
Alpha Win Capital investment in Series B - Treadwell Therapeutics
Prosperous Alliance Investments
Prosperous Alliance Investments investment in Series B - Treadwell Therapeutics
3W Fund Management
3W Fund Management investment in Series B - Treadwell Therapeutics
TIO Bioventures
TIO Bioventures investment in Series B - Treadwell Therapeutics
Sino Biopharmaceutical
Sino Biopharmaceutical investment in Series B - Treadwell Therapeutics
Adrian Cheng
Adrian Cheng investment in Series B - Treadwell Therapeutics
Fortune Ocean Growth Fund
Fortune Ocean Growth Fund investment in Series B - Treadwell Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-19 | Treadwell Therapeutics Announces the Appointment of J.D. Mowery, as Chief Operating Officer |
Official Site Inspections
http://www.treadwelltx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
